Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

SUS 99-015 – HSR Study

 
SUS 99-015
System for Monitoring Substance Abuse Patients' Outcomes and Care
John W. Finney, PhD
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, CA
Quyen Tiet PhD
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, CA
Funding Period: July 2000 - June 2005
Portfolio Assignment: Mental and Behavioral Health
BACKGROUND/RATIONALE:
Substance use disorders (SUDs) are exceedingly prevalent and costly among VA patients. In Fiscal Year 2000 (FY00), 21 percent of the 353,200 unique VA inpatients had a primary or secondary substance abuse or dependence diagnosis. These patients accounted for 1.2 million days of inpatient care. In addition, 9 percent of the 3.64 million VA outpatients had an alcohol or drug diagnosis in FY00. In all, 124,300 patients received specialized outpatient substance abuse care in FY00. As a result of its prevalence, SUDs were one of eight medical/psychiatric conditions initially targeted in the VA’s Quality Enhancement Research Initiative (QUERI).

OBJECTIVE(S):
To monitor VA SUD patients’ outcomes and care, the VA, until recently, required that all new patients in specialized treatment programs receive an assessment based on the Addiction Severity Index (ASI) at intake. Patients were supposed to be followed up by program staff with another 45-60-minute ASI interview six months later. This system was burdensome for program staff and yielded low (e.g., 20%) follow-up rates and unrepresentative outcome data. The current project evaluates a more efficient outcomes monitoring system (OMS) for assessing VA SUD patients' outcomes and linking them to the care patients have received.

METHODS:
The OMS is testing a more efficient system for monitoring VA SUD patients’ outcomes and care. Using a quasi-experimental, pretest-posttest design in which patients are assessed at treatment intake and at a six-month follow up, treatment type and program comparisons will be made after controlling for patient casemix differences. Building on the previous mandated ASI interview-based system, a self-report instrument made up of ASI "composite score" items was used to gather information on patients’ symptoms and functioning at intake and follow up. Intake data were obtained annually from representative samples of patients in each of a representative sample of 50-55 specialized SUD treatment programs. For annual Cohorts 1-3, intake data were obtained for 1,968, 1,718, and 2,021 patients, respectively. Patient follow ups were conducted by OMS staff primarily via mailed surveys, with some telephone interviews, as needed. Casemix adjustment and additional patient data, as well as information on guideline-concordant treatment practices and costs, are being obtained from national VA databases. Additional data on guideline-concordant treatment practices have been gathered from annual surveys of the directors of the selected SUD programs. Costs of conducting follow-ups using this system will be estimated.

FINDINGS/RESULTS:
The follow-up rate for all three cohorts was 65% or higher, substantially superior to the 20% rate achieved by program staff under the mandated monitoring system. Preliminary findings indicate that VA SUD patients exhibit significant improvement alcohol and substance use and related problems. In addition, preliminary analyses have found that more employment services in SUD programs are linked to better employment outcomes for patients in inpatient/residential SUD programs, whereas higher levels of psychological services are related to reduced rates of drug use and problem drinking for patients with greater baseline psychological problems, but only in outpatient SUD programs. VA SUD treatments also appear effective for suicidal SUD patients, and these patients were particularly responsive to treatment in inpatient settings.

IMPACT:
This project is testing a practical, efficient system for monitoring the outcomes and care for VA patients treated for substance use disorders. Project findings to date support the feasibility of the methods used. If the system were adopted systemwide, it would allow the VA determine the impact of quality improvement efforts in the VA SUD treatment system. Project data will be used to estimate the effectiveness and cost-effectiveness of different forms of VA SUD care, identify types of treatment settings that are optimal for different types of patients, and determine the relationship between process (e.g., continuing care) and outcome indicators of program performance.


External Links for this Project

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:

None at this time.


DRA: Substance Use Disorders, Health Systems Science, Mental, Cognitive and Behavioral Disorders
DRE: none
Keywords: Clinical practice guidelines, Patient outcomes, Quality assurance, improvement, Research method, Screening
MeSH Terms: none

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.